2022
Identification of patients with Graves’ disease who benefit from high-dose radioactive iodine therapy
Watanabe S, Okamoto S, Akikawa K, Miyamoto N, Okamura-Kawasaki M, Uchiyama Y, Takenaka J, Toyonaga T, Hirata K, Kudo K. Identification of patients with Graves’ disease who benefit from high-dose radioactive iodine therapy. Annals Of Nuclear Medicine 2022, 36: 923-930. PMID: 35972673, DOI: 10.1007/s12149-022-01781-1.Peer-Reviewed Original ResearchConceptsProbability of remissionHigh-dose RAIRemission rateThyroid-stimulating antibodiesGraves' diseaseIodine therapyDose groupHD groupThyroid volumeHigh-dose radioactive iodine (RAI) therapyThyroid hormone replacement therapyMultivariate logistic regression analysisLD groupHigher RAI doseRadioactive iodine therapyCharacteristics of patientsOverall remission rateHormone replacement therapyLow-dose groupHigh-dose groupIdentification of patientsLogistic regression analysisMultivariate analysis resultsDose RAIRAI dose
2019
Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016
Ross JS, Rohde S, Sangaralingham L, Brito JP, Choi L, Dutcher SK, Graham DJ, Jenkins MR, Lipska KJ, Mendoza M, Qiang Y, Wang Z, Wu Y, Yao X, Shah ND. Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016. The Journal Of Clinical Endocrinology & Metabolism 2019, 104: 2305-2314. PMID: 30690529, DOI: 10.1210/jc.2018-02197.Peer-Reviewed Original ResearchConceptsBrand-name useDrug useMedicare AdvantageThyroid hormone replacement therapyLarge administrative claims databaseBeneficiary populationAdministrative claims databaseHormone replacement therapyCertain patient characteristicsMedicare Part DPrescriber specialtyPatient characteristicsPrescriber characteristicsClaims databaseReplacement therapyGeneric levothyroxineWhite raceHealth plansOlder adultsHormone drugsInsurance coverageProduct useLevothyroxineNational dataPart D
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply